TON - Evolving Guidelines

Evolving Guidelines: The Treatment Landscape in Ovarian Cancer: A Focus on PARP Inhibitors

TLG1896

The Treatment Landscape in Ovarian Cancer: A Focus on PARP Inhibitors

This supplement reviews outcomes from several key trials, examines the use of PARP inhibitors and other emerging treatments, and discusses several changes recently made to treatment recommendations from NCCN and ASCO and how those changes can be incorporated into clinical practice. Read More ›

Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive:

TON Print Edition

TON Weekly e‑Newsletter

I have reviewed and consent to the terms of TON's Privacy Policy, and TON has my permission to retain my information in its database, and to forward pertinent communications to me.